Big Problems At A Syringe Supplier Led To B. Braun's $7.8m Settlement With Feds
This article was originally published in The Gray Sheet
Executive Summary
The company distributed contaminated syringes manufactured by a third party despite repeated indications that not all was well with the supplier's practices, the Department of Justice says.
You may also be interested in...
Reimbursement Support Programs Create 'Holy Trinity' Of Enforcement Risk
Services that help doctors' offices navigate payment hurdles could draw government scrutiny for false claims, kickbacks, and medical privacy violations, attorney says.
US Health-Care Enforcement Focus Continues To Expand, Officials Say
Reimbursement efforts, individual liability and innovative corporate integrity agreements were among areas of focus at a recent Food and Drug Institute enforcement forum.
Scrip M&A Podcast: Which Companies Could Be Acquired Next?
The editorial team from Scrip discusses the M&A potential of various emerging biopharmas, such as Viking, Verona, Altimmune, Xenon and Crinetics.